Coming Soon: Antibody Drug Conjugates

Coming Soon: Antibody Drug Conjugates

UPCOMING Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in Antibody Drug Conjugates Giuseppe Banna Portsmouth Hospitals NHS Trust, UK Alessandra Curioni Cantonal Hospital Fribourg,...
Breast Cancer (ASCO 2024)

Breast Cancer (ASCO 2024)

Breast Cancer (ASCO 2024) Welcome & introduction by host Jens Huober Latest treatment updates in early breast cancer Konstantin Dedes How does the latest ASCO data integrate into the treatment of TNBC and HER2+ advanced breast cancer? Isabell Witzel Where do we stand...
GI Cancers (ASCO 2024)

GI Cancers (ASCO 2024)

GI Cancers (ASCO 2024) Welcome & introduction by host Thibaud Kössler NEW TREATMENT UPDATES IN UPPER GI ELIZABETH SMYTH LATEST INSIGHTS FOR HCC AND PANCREATIC CANCER SARA DE DOSSO HIGHLIGHTED DATA FROM ASCO FOR CRC THIBAUD KÖSSLER  } 1 h 31 min Get Your CME...
Lung Cancer (ASCO 2024)

Lung Cancer (ASCO 2024)

Lung Cancer (ASCO 2024) Welcome & introduction by host Alfredo Addeo WHAT’S NEW IN TARGETED THERAPIES FOR NSCLC? XIUNING LE LATEST INSIGHTS IN ADCS FOR LUNG CANCER LIZZA HENDRIKS NEW ADVANCES IN IMMUNOTHERAPIES FOR LUNG CANCER ALFREDO ADDEO  } 1 h 32 min Get Your...
Prostate & Urothelial Cancer

Prostate & Urothelial Cancer

Prostate & Urothelial Cancer Welcome & introduction by host Aurelius Omlin How to integrate the new treatment options in mHSPC and mCRPC Deborah Mukherji First-line mUC: how to manage patients on the enfortumab-pembrolizumab combination Alison Birtle Open...